These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23401647)

  • 21. The treatment of sexual offenders: castration and antihormone therapy.
    Ortmann J
    Int J Law Psychiatry; 1980; 3(4):443-51. PubMed ID: 6456239
    [No Abstract]   [Full Text] [Related]  

  • 22. The hormonal treatment of sexual offenders.
    Bradford JM
    Bull Am Acad Psychiatry Law; 1983; 11(2):159-69. PubMed ID: 6225477
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review.
    Turner D; Briken P
    J Sex Med; 2018 Jan; 15(1):77-93. PubMed ID: 29289377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cyproteronacetat treatment of sexual offenders.
    Berner W; Brownstone G; Sluga W
    Neurosci Biobehav Rev; 1983; 7(3):441-3. PubMed ID: 6230546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review.
    Briken P; Hill A; Berner W
    J Clin Psychiatry; 2003 Aug; 64(8):890-7. PubMed ID: 12927003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological agents for treatment of paraphilias and hypersexual disorders].
    Hebebrand K; Hebebrand J; Remschmidt H
    Fortschr Neurol Psychiatr; 2002 Sep; 70(9):462-75. PubMed ID: 12215919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate].
    Briken P; Berner W; Noldus J; Nika E; Michl U
    Nervenarzt; 2000 May; 71(5):380-5. PubMed ID: 10846713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential pharmacological treatment of paraphilias and sex offenders.
    Hill A; Briken P; Kraus C; Strohm K; Berner W
    Int J Offender Ther Comp Criminol; 2003 Aug; 47(4):407-21. PubMed ID: 12971182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Did you say chemical castration?
    Bund JM
    Univ Pittsbg Law Rev; 1997; 59(1):157-92. PubMed ID: 14631990
    [No Abstract]   [Full Text] [Related]  

  • 30. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles.
    Cooper AJ; Sandhu S; Losztyn S; Cernovsky Z
    Can J Psychiatry; 1992 Dec; 37(10):687-93. PubMed ID: 1473073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer.
    Spitz IM; Chertin B; Lindenberg T; Farkas A
    N Engl J Med; 1999 May; 340(18):1439. PubMed ID: 10328706
    [No Abstract]   [Full Text] [Related]  

  • 32. Research on sex offenders. Recent trends.
    Bradford JM
    Psychiatr Clin North Am; 1983 Dec; 6(4):715-31. PubMed ID: 6229722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antilibidinal drugs and mental retardation: a review.
    Clarke DJ
    Med Sci Law; 1989 Apr; 29(2):136-46. PubMed ID: 2526280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a best endocrine management of prostatic carcinoma?
    Robinson MR
    Prog Clin Biol Res; 1988; 269():147-58. PubMed ID: 2969114
    [No Abstract]   [Full Text] [Related]  

  • 35. [Medical prevention of recidivism by sexual delinquents].
    Milgrom E; Bouchard P; Olié JP
    Bull Acad Natl Med; 2010 Jun; 194(6):1033-44. PubMed ID: 21513136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urolithiasis in the Long-Term GnRH Agonist Treatment of Patients with Paraphilia: 3 Case Studies].
    Mayrhofer G; Wegner D; Voß T
    Aktuelle Urol; 2016 Dec; 47(6):487-490. PubMed ID: 27701680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of sex offenders with Depo-Provera.
    Kiersch TA
    Bull Am Acad Psychiatry Law; 1990; 18(2):179-87. PubMed ID: 2142608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol.
    Bruchovsky N; Goldenberg SL; Akakura K; Rennie PS
    Cancer; 1993 Sep; 72(5):1685-91. PubMed ID: 7688656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychosocial and biological treatment considerations for the paraphilic and nonparaphilic sex offender.
    Saleh FM; Guidry LL
    J Am Acad Psychiatry Law; 2003; 31(4):486-93. PubMed ID: 14974804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders.
    Saleh FM; Berlin FS
    J Child Sex Abus; 2003; 12(3-4):233-53. PubMed ID: 15308453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.